Kari Ring

Gynecologic Oncologist

[Kari Ring @KariLRing]

@aaronshafer99 @RTylerHillmanMD @DrRobDood @JDottinoMD @AmirJazaeri this is hilarious. 🤣 congrats to the graduates!

[Pamela T. Soliman MD @PamSolimanMD]

Exciting to share treatment options that are better than chemotherapy for women with #endometrialcancer #clinicaltrial #gyncsm #endcancer #oncsurgery @karenluMD @rcoledude @ShannonWestin @DavidIglesiasMD @MDAndersonNews

[BJ Rimel @BJRimelMD]

Seems like we are done with MIS for cervical cancer. Even distance from margin was the same and the “less worrisome” uterine manipulators were showed higher rates of recurrence. The only thing left is the CO2....

[OncLive.com @OncLive]

Dr. Katherine Kurnit, of @MDAndersonNews, walked us through her study comparing whether a gynecologic or gastrointestinal regimen is better for patients with mucinous ovarian cancer who are dispositioned to receive chemo. Stay tuned for the interview! #SGOWinter #SGO2019 @SGO_org

[Shannon Westin, MD, MPH, FASCO @ShannonWestin]

Another great talk at the @GYNCancer #Survivor course - @temkins breaking down #CA125 in #ovariancancer #gyncsm

[Sarah Temkin @temkins]

We're talking about digital health with @BJRimelMD and the foundation for women's cancer. #gyncsm #ovariancancer #survivors course #RVA

[Sarah Temkin @temkins]

@ShannonWestin talks clinical trials in #RVA for #ovariancancer #gyncsm @SGO_org

[Filip Janku @FilipJankuMD]

Amazing data for the olaparib maintenance after the first line chemotherapy in advanced #ovariancancer with somatic it germline BRCA mutation presented at #ESMO18 #PrecisionMedicine

[Dee Sparacio @womenofteal]

SGO recommends genetic testing for all women dx w #ovca. even if no family history - a new position paper http://t.co/GjqF8dewR6 #gyncsm

[Wendel Naumann @wendel_naumann]

Data from older clinical trials now available to researchers for new discoveries! #sgo2014 http://t.co/8EmR2bsljM

[The ASCO Post @ASCOPost]

Anastrozole Reduces Breast Cancer Incidence in High-Risk Postmenopausal Women http://t.co/Hw5auGK2nj #bcsm

[SGO @SGO_org]

Women with BRCA1 mutation might use medications to reduce their risk of developing breast and ovarian cancer. http://t.co/raBM8QPcAQ

[Jeff F. Lin @JeffLinMD]

http://t.co/OcRTIF6jXB #SGO2014

[Mario M. Leitao, Jr @leitaomd]

GOG 249 presented at SGO. Chemotherapy not superior to Pelvic XRT in high-intermediate risk uterine carcinoma. #SGO2014

[Nadeem R. Abu-Rustum @aburustummd]

GOG 249 Endometrial ca trial Dr McMeekin conclusions slide

[Douglas Levine MD @levinemd]

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. http://t.co/w995BZGPGY